Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
Multipotency and Niche of Bulge Stem Cell01:06

Multipotency and Niche of Bulge Stem Cell

3.4K
A hair follicle or HF is a small part of the skin that produces the hair shaft. Paul Gerson Unna was the first to observe a bulge in the human hair follicle's outer root sheath (ORS). The bulge is present between the sebaceous gland and the arrector pili muscle and is the niche for hair follicle stem cells (HFSCs). The bulge is also a niche for melanocyte stem cells, and their loss results in graying of hair. The HFSCs express Sox9 and Lhx2, which help them maintain stemness and prevent...
3.4K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

162
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
162
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

3.0K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges - A Narrative Review.

Journal of inflammation research·2026
Same author

Segmental Heterochromia with calibre change: a rare sign of Alopecia Areata.

Clinical and experimental dermatology·2026
Same author

Paediatric-Onset Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum: Is It a Different Disease?

Experimental dermatology·2026
Same author

Metabolic and Vascular Inflammation in Alopecia Areata: Linking Uric Acid, Lipid Imbalance and ICAM-1 Upregulation.

Experimental dermatology·2025
Same author

British Association of Dermatologists living guideline for managing people with alopecia areata 2025.

The British journal of dermatology·2025
Same author

Findings from the Assessment of real-world Disease characteristics and outcomes in Alopecia Areata in a Global non-Interventional Observational cohort (ADAAGIO) study.

Clinical and experimental dermatology·2025

Related Experiment Video

Updated: Jun 4, 2025

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

8.9K

Frontal Fibrosing Alopecia: An Update.

Andrew G Messenger1, Leila Asfour2, Matthew Harries3,4

  • 1University of Sheffield, Sheffield, UK. a.g.messenger@sheffield.ac.uk.

American Journal of Clinical Dermatology
|December 19, 2024
PubMed
Summary
This summary is machine-generated.

Frontal fibrosing alopecia (FFA) is increasingly common, with genetic and environmental factors contributing to its cause. Early diagnosis and novel treatments are crucial for preventing disease progression.

More Related Videos

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
03:22

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

15.0K
Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
06:04

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE

Published on: August 16, 2024

737

Related Experiment Videos

Last Updated: Jun 4, 2025

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

8.9K
Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
03:22

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

15.0K
Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
06:04

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE

Published on: August 16, 2024

737

Area of Science:

  • Dermatology
  • Pathology
  • Genetics

Background:

  • Frontal fibrosing alopecia (FFA) has seen a significant rise in prevalence since 1994.
  • Familial cases suggest a genetic predisposition, while epidemiological data points to environmental triggers.

Purpose of the Study:

  • To review recent advancements in understanding FFA's etiology, pathology, and treatment.
  • To highlight the ongoing search for causal links between environmental factors and FFA.

Main Methods:

  • Review of genetic studies confirming inherited predisposition.
  • Analysis of epidemiological data implicating environmental factors like skincare products and exogenous estrogens.
  • Clarification of pathological mechanisms, including inflammation and epithelial-mesenchymal transition.

Main Results:

  • Genetic predisposition to FFA is confirmed.
  • Environmental factors, particularly personal care products and UV filters, are suspected but not definitively linked.
  • Pathological mechanisms involve inflammatory components, loss of follicular immune privilege, and epithelial-mesenchymal transition.

Conclusions:

  • FFA likely involves both genetic and environmental factors.
  • Lichen planus pigmentosus may be part of the same pathology, offering etiological clues.
  • Early diagnosis and novel treatments, including Janus kinase inhibitors, are key for managing FFA progression.